Amitriptyline Contraindications
Amitriptyline is absolutely contraindicated in patients with prior hypersensitivity to the drug, those currently taking or who have taken monoamine oxidase inhibitors (MAOIs) within the past 14 days, those receiving cisapride, and during the acute recovery phase following myocardial infarction. 1
Absolute Contraindications
The FDA-approved drug label establishes the following absolute contraindications 1:
- Prior hypersensitivity to amitriptyline
- Concomitant MAOI use - Hyperpyretic crises, severe convulsions, and deaths have occurred when tricyclic antidepressants are combined with MAOIs. A minimum 14-day washout period is mandatory after discontinuing an MAOI before initiating amitriptyline 1
- Concurrent cisapride administration - Due to potential QT interval prolongation and increased arrhythmia risk 1
- Acute recovery phase post-myocardial infarction 1
Major Warnings and Precautions (Relative Contraindications)
Multiple clinical practice guidelines identify conditions requiring extreme caution or avoidance 2:
Cardiac Conditions
- Heart failure 2
- Cardiovascular disorders - Patients require close monitoring as amitriptyline can produce arrhythmias, sinus tachycardia, and prolonged conduction time. Myocardial infarction and stroke have been reported 1
- QT prolongation risk - Amitriptyline causes prolonged QTc on ECG 3. Avoid in patients with long QT syndrome or those taking other QT-prolonging medications 4
Neurological Conditions
- Angle-closure glaucoma - Even average doses may precipitate an acute attack due to anticholinergic effects 2, 1
- Increased intraocular pressure 1
- History of seizures - Use with caution as amitriptyline may lower seizure threshold 1
Age-Related Contraindications
- Age <6 years 2
- Pediatric patients <12 years - Not recommended due to lack of safety and efficacy data 1
Other Important Precautions
- Urinary retention history - Anticholinergic effects can exacerbate this condition 1
- Hyperthyroidism or thyroid medication use - Close supervision required 1
- Pregnancy - Should only be used if potential benefit justifies fetal risk. Topiramate is explicitly contraindicated in pregnancy, making amitriptyline a potential alternative under specialist supervision 2, though it should generally be avoided 3
- Parkinsonism - Listed as contraindication for related tricyclics 2
Critical Drug Interactions (Functional Contraindications)
Beyond MAOIs and cisapride, several drug combinations require avoidance or extreme caution 4, 1:
Serotonergic Drugs
Combining amitriptyline with other serotonergic agents increases risk of potentially fatal serotonin syndrome 4. Exercise extreme caution with:
- SSRIs (especially problematic due to CYP2D6 inhibition) 4, 1
- SNRIs
- Other tricyclic antidepressants
- Tramadol, meperidine, methadone, fentanyl
- Dextromethorphan
- St. John's wort, L-tryptophan
CYP450 Interactions
Co-administration with SSRIs requires particular caution as they inhibit CYP2D6, potentially causing 8-fold increases in amitriptyline plasma levels 5, 1. When switching from fluoxetine to amitriptyline, wait at least 5 weeks due to fluoxetine's long half-life 1.
Other Significant Interactions
- Anticholinergic agents - Risk of hyperpyrexia, especially in hot weather 1
- Sympathomimetic drugs including epinephrine with local anesthetics 1
- Topiramate - Can cause large increases in amitriptyline concentration 1
Special Population Considerations
Geriatric Patients
Elderly patients are particularly vulnerable to anticholinergic side effects including cognitive impairment, confusion, delirium, falls, tachycardia, urinary retention, and constipation 1. Tertiary-amine TCAs like amitriptyline are considered potentially inappropriate medications in the Beers Criteria for older adults 6. Start with low doses (approximately 50% of standard adult starting dose) and monitor closely 6, 1.
Pharmacogenomic Considerations
CYP2D6 poor metabolizers should receive 50% dose reduction or consider alternatives like nortriptyline or desipramine. CYP2D6 ultrarapid metabolizers and CYP2C19 poor metabolizers/ultrarapid metabolizers should consider alternatives 5.
Common Pitfalls to Avoid
- Failing to screen for bipolar disorder before initiating treatment - Amitriptyline may precipitate manic episodes in undiagnosed bipolar patients 1
- Inadequate MAOI washout period - Always ensure 14 days have elapsed 1
- Overlooking alcohol use - Amitriptyline potentiates alcohol effects and increases suicide/overdose risk in patients who use alcohol excessively 1
- Ignoring cardiac history in elderly - Cardiovascular effects are particularly problematic in this population 1
- Prescribing in pregnancy without specialist consultation - While sometimes used under supervision for migraine prophylaxis when benefits outweigh risks 2, it should generally be avoided 3
Real-world data shows that nearly half (46.7%) of patients prescribed amitriptyline for painful neuropathic disorders had at least one preclusion for its use, with higher rates in women, elderly patients, and those with multiple comorbidities 7. This underscores the importance of careful patient selection and monitoring.